References

1. Stehling L, Simon TL: The red blood cell transfusion trigger: physiology and clinical studies. Arch Pathol Lab Med 118:429-434, 1994.

2. Rossi EC: Red cell transfusion therapy in chronic anemias. Hematol Oncol Clin North Am 8:1045-1052, 1994.

3. Welch HG, Meehan KR, Goodnough LT: Prudent strategies for elective red blood cell transfusion. Ann Intern Med 116:393-402, 1992.

4. American College of Physicians. Practice strategies for elective red blood cell transfusion. Ann Intern Med 116:403-406, 1992.

5. A Report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Practice guidelines for blood component therapy. Anesthesiology 84:732-747, 1996.

6. British Committee for Standards in Haematology. Guidelines for the clinical use of red cell transfusions. Br J Haematol 113:24-31, 2001.

7. Hoeltge GA, Domen RE, Rybicki LA, Schaffer PA: Multiple red cell transfusions and alloimmunization: experience with 6996 antibodies detected in a total of 159, 262 patients from 1985 to 1993. Arch Pathol Lab Med 119:42-45, 1995.

8. Schonewille H, Haak HL, van Zijl AM: RBC antibody persistence. Transfusion 40:1127-1131, 2000.

9. Friedberg RC: Transfusion therapy in the patient undergoing hematopoietic stem cell transplantation. Hematol Oncol Clin of North Am 8:1105-1116, 1994.

10. Brecher ME (ed.): Technical Manual, 14th edn. Bethesda, MD: AABB Press; 2002.

11. Bolan CD, Childs RW, Procter JL, Barrett AJ, Leitman SF: Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility. Br J Haematol 112:787-795, 2001.

12. Sniecinski IJ, Petz LD, Oien L, Blume KG: Immunohematologic problems arising from ABO incompatible bone marrow transplantation. Transplant Proceed 19:4609-4611, 1987.

13. Sniecinski IJ, Oien L, Petz LD, Blume KG: Immunohematologic consequences of major ABO-mismatched bone marrow transplantation. Transplantation 45:530-534, 1988.

0 0

Post a comment